← Leaderboards
Bernadette Chen
Research Inst Nationwide Children'S Hosp
$3,224,093
Attributed
$3,224,093
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $512.4K · FY2011–22$1M$750K$500K$250K$0
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
Funding mix
By agency
NIH$3,224,093 · 3
By mechanism
R01$2,440,443 · 1
K08$633,150 · 1
R03$150,500 · 1
Top collaborators
No co-investigators on record.
Most similar at Research Inst Nationwide Children'S Hosp
Same institution · by research overlap
- Laurence A Greenbaum$5,008,224
- Michelle N. Rheault$880,945
- Diana Zepeda-Orozco$2,467,120
Others in their field
Top investigators on “Pulmonary Vascular Resistance”
- Kathryn Hirst · Caritas St. Elizabeth'S Medical Center$57,671,528
- Jason X.-J. Yuan · University Of California, San Diego$15,701,166
- You-Yang Zhao · University Of Illinois At Chicago$10,626,348
- Marlene Rabinovitch · Stanford University$9,725,758
- Elena Goncharova · Boston University Medical Campus$8,485,458
- Katie L Stone · University Of California San Francisco$8,317,803
Research focus
Pulmonary Vascular ResistanceSmooth Muscle MyocytesPathogenesisPulmonary HypertensionResponseSideCell ProliferationLifePreventionProtein IsoformsPressurePhysiologic Intraventricular PressureHeartHypertensionAnimal ModelCell Culture TechniquesKnock-OutCessation Of LifeLungNew Therapeutic TargetBlood VesselsCaliberPrematureVascular Remodeling
Grant awards (12)
Regulation of PDE3 in the Pathobiology of Pulmonary Hypertension$506,476
R01 · FY2022 · HL · contact PI
Regulation of PDE3 in the Pathobiology of Pulmonary Hypertension$506,411
R01 · FY2021 · HL · contact PI
Regulation of PDE3 in the Pathobiology of Pulmonary Hypertension$506,350
R01 · FY2020 · HL · contact PI
Regulation of PDE3 in the Pathobiology of Pulmonary Hypertension$512,369
R01 · FY2019 · HL · contact PI
Regulation of PDE3 in the Pathobiology of Pulmonary Hypertension$408,837
R01 · FY2018 · HL · contact PI
The Role of Arginase 2 in Chronic Hypoxia-Induced Pulmonary Hypertension.$75,250
R03 · FY2018 · HL · contact PI
The Role of Arginase 2 in Chronic Hypoxia-Induced Pulmonary Hypertension.$75,250
R03 · FY2017 · HL · contact PI
Regulation of Arginase in Models of Pulmonary Hypertension$126,630
K08 · FY2015 · HL · contact PI
Regulation of Arginase in Models of Pulmonary Hypertension$126,630
K08 · FY2014 · HL · contact PI
Regulation of Arginase in Models of Pulmonary Hypertension$126,630
K08 · FY2013 · HL · contact PI
Regulation of Arginase in Models of Pulmonary Hypertension$126,630
K08 · FY2012 · HL · contact PI
Regulation of Arginase in Models of Pulmonary Hypertension$126,630
K08 · FY2011 · HL · contact PI